Journals / Nöropsikiyatri Arşivi / 2013 / Cilt: 50 - Sayı: 2

Tardive Dyskinesia Due to Olanzapine in an Adolescent with Psychosis and its Treatment with Clozapine

Psikotik Bir Ergen Hastada Olanzapine Bağlı Tardif Diskinezi ve Klozapin ile Tedavisi

Pages
183–185
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Considering the increase in long-term use of atypical antipsychotics in children and adolescents for various indications, it can be though that further studies on the phenomenology, diagnosis and methods of treatment of TD in those patients are required. (Archi ves of Neuropsychiatry 2013; 50: 183-185)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Atypical antipsychotics are increasingly being used in the current clinical approach for the treatment of various psychopathologies in children and adolescents.
📊
Key Findings & Data:In this study, we aimed to present the diagnosis of TD duelong-term use of olanzapine and successful treatment with clozapine in an adolescent patient who has been followed with the diagnoses of moderate mental retardation and undifferentiated schizophrenia.
💡
Conclusion & Impact:Considering the increase in long-term use of atypical antipsychotics in children and adolescents for various indications, it can be though that further studies on the phenomenology, diagnosis and methods of treatment of TD in those patients are required. (Archi ves of Neuropsychiatry 2013; 50: 183-185)
🔬Design:Research Article
📍Scope:2013 Verileri
⚙️Variables:Domain Parameters

Abstract

Atypical antipsychotics are increasingly being used in the current clinical approach for the treatment of various psychopathologies in children and adolescents. The common use of atypical antipsychotics in this age group may lead to various consequences, including movement disorders, such as tardive dyskinesia (TD). In this study, we aimed to present the diagnosis of TD duelong-term use of olanzapine and successful treatment with clozapine in an adolescent patient who has been followed with the diagnoses of moderate mental retardation and undifferentiated schizophrenia. It may be posited that female adolescents with chronic illnesses, receiving long-term antipsychotic medication, with affective and negative symptoms, mental retardation, and teeth infections should be monitored regularly for TD. Clozapine may be a choice in the treatment of tardive dyskinesia developing in adolescent patients. Considering the increase in long-term use of atypical antipsychotics in children and adolescents for various indications, it can be though that further studies on the phenomenology, diagnosis and methods of treatment of TD in those patients are required. (Archi ves of Neuropsychiatry 2013; 50: 183-185)

Özet

Güncel klinik yaklaşımda çocuk ve ergenlerdeki çeşitli psikopatolojilerin tedavisi için atipik antipsikotiklere giderek artan bir sıklıkla başvurulmaktadır. Atipik antipsikotiklerin bu yaş grubunda yaygın olarak kullanımı, tardiv diskinezi (TD) gibi hareket bozukluklarını da içeren çeşitli sonuçlara yol açabilir. Bu çalışmada Orta Derecede Mental Retardasyon ve Farklılaşmamış Şizofreni tanılarıyla takip edilen bir ergen hastada uzun süreli olanzapin kullanımı sonrasında ortaya çıkan TD’nin tanısı ve klozapinle başarılı bir şekilde tedavisinin bildirilmesi amaçlanmıştır. Süreğen hastalığı, uzun süreli antipsikotik kullanımı, afektif ve negatif semptomları, mental retardasyonu ve diş enfeksiyonları olan kız ergen hastaların tardif diskinezi riski açısından belirli aralıklarla değerlendirilmesi gerektiği önerilebilir. Klozapin ergen hastalarda gelişen tardif diskinezinin tedavisinde bir seçenek olabilir. Atipik antipsikotiklerin çocuk ve ergenlerde çeşitli endikasyonlarla uzun sürelerle kullanımının giderek yaygınlaştığı göz önüne alındığında, bu hastalardaki TD’nin görünümü, tanısı ve tedavi yöntemleri hakkında ileri araştırmaların gerektiği düşünülebilir. ( Nöropsikiyatri Arşivi 2013; 50: 183-185)

🔖

Cite This Article

TUFAN, A. E., BİİLİCİ, R., UĞURLU, G. K., YILMAZ, S., ERDOĞAN, A. (2013). Tardive Dyskinesia Due to Olanzapine in an Adolescent with Psychosis and its Treatment with Clozapine. Nöropsikiyatri Arşivi, Cilt: 50 - Sayı: 2, 183–185. https://ajindex.com/articles/292592

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Kumra S, Jacobsen LK, Lenane M, Smith A, Lee P, Malanga CJ, KarpHamburger S, Rapoport JL. Case series: spectrum of neuroleptic-induced movement disorders and extrapyramidal side effects in childhood- onseschizophrenia. J Am Acad Child Adolesc Psychiatry 1998; 37: 221-227.
  2. Olfson M, Blanco C, Liu L, Moreno C, Laje G. National trends in the outpatient treatment of children and adolescents with antipsychotic drugsArch Gen Psychiatry 2006; 63: 679-685. American Psychiatric Association: Diagnostic and Statistical ManualMental Disorders, fourth ed. Washington. DC: American Psychiatric Association, 1994 Owens DGC. Tardive dyskinesia. A guide to the ekstrapyramidal side effects of antipsychotic drugs içinde. Cambridge, UK: Cambridge University Press, 1999; s. 166-226.
  3. Egan MF, Apud J, Wyatt RJ. Treatment of tardive dyskinesia. Schizophr Bul1997; 23: 583-609.
  4. Connor DF, Fletcher KE, Wood JS. Neuroleptic-related dyskinesiaschildren and adolescents. J Clin Psychiatry 2001; 62: 967-974.
  5. Erdogan A, Karaman MG, Ozdemir E, Yurteri N, Tufan AE, Kurcer MA. Six months of treatment with risperidone may be associated with nonsignificant abnormalities of liver function tests in children and adolescents: a longitudinal, observational study from Turkey. J Child Adolesc Psychopharmacol 2010; 20: 407- 413. Correll CU, Kane JM. One-year incidence rates of tardive dyskinesiachildren and adolescents treated with second-generation antipsychotics:systematic review. J Child Adolesc Psychopharmacol. 2007; 17 (5): 647- 656 Ugurlu GK, Tufan E, Bilici R, Ugurlu M, Saglam S. Olanzapine induced ardive dyskinesia treated successfully with quetiapine: A case reportProg Neuropsychopharmacol Biol Psychiatry 2011; 35: 276-277. Simpson GM. The treatment of tardive dyskinesia and tardive dystonia.Clin Psychiatry. 2000;61 Suppl 4:39-44.
  6. Woods SW, Martin A, Spector SG, McGlashan TH. Effects of developmenon olanzapine-associated adverse events. J Am Acad Child Adolesc Psychiatry 2002; 41: 1439-1446.
  7. Dankı D, Dilbaz N, Okay İT. Valproata ek olarak düşük doz olanzapin kullanımına bağlı şiddetli ekstrapiramidal bulgular: bir olgu. Klinik Psikofarmakoloji Bülteni 2006; 16 (1): 42-46
  8. Bozabalı ÖG, Baykara B, Baykara A. Çocuk ve ergenlerde 5 farklpsikiyatrik bozuklukta olanzapin kullanımı. Klinik PsikofarmakolojBülteni 2002; 12: 179-183.
  9. Janicak PG, Beedle D. Neuroleptic-induced tardive dyskinesia. Kaplan and Sadock’s Comprehensive Textbook of Psychiatry içinde. 8th EditionSadock BJ, Sadock VA (ed). Philadelp